Zhen Shi

838 total citations
36 papers, 569 citations indexed

About

Zhen Shi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Zhen Shi has authored 36 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Zhen Shi's work include Genomics and Rare Diseases (6 papers), Metabolism and Genetic Disorders (5 papers) and Genetics and Neurodevelopmental Disorders (5 papers). Zhen Shi is often cited by papers focused on Genomics and Rare Diseases (6 papers), Metabolism and Genetic Disorders (5 papers) and Genetics and Neurodevelopmental Disorders (5 papers). Zhen Shi collaborates with scholars based in China, United States and Spain. Zhen Shi's co-authors include Hans P. Blaschek, John Moult, Matthew Wongchenko, Steven J. Isakoff, Eva Ciruelos, Begoña Bermejo, Mafalda Oliveira, Paolo Nucíforo, Cristina Saura and Isabel Calvo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Molecular Biology.

In The Last Decade

Zhen Shi

31 papers receiving 564 citations

Peers

Countries citing papers authored by Zhen Shi

Since Specialization

Citations

This map shows the geographic impact of Zhen Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Shi more than expected).

Fields of papers citing papers by Zhen Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Shi. The network helps show where Zhen Shi may publish in the future.

Co-authorship network of co-authors of Zhen Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen Shi. A scholar is included among the top collaborators of Zhen Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen Shi. Zhen Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Application of comprehensive geriatric assessment in oncology nursing: A literature review on optimizing treatment decisions and patient outcomes 2025 ·World Journal of Clinical Oncology ·Chengjin Li, (unknown), Yujuan Shi, Yanan Guo, Nana Song, (unknown), Yanyan Wang, Changjiang Zhang, (unknown), Zhipeng Li, Peng Wang, Yuhua Ruan, Zhen Shi, Haoyu Li, (unknown), Weiping Fu	0
2	Nutritional status of elderly hypertensive patients and its relation to the occurrence of cognitive impairment 2025 ·World Journal of Psychiatry ·Qiao Xu, (unknown), Zhen Shi, (unknown), Jie Yu, Zhuo Wang, (unknown), (unknown)	1
3	Prevalence and risk factors for painful diabetic peripheral neuropathy: a systematic review and meta-analysis 2025 ·Frontiers in Neurology ·Peng Zhou, (unknown), Jianping Li, Lang Qin, (unknown), (unknown), Jian Wang, Zhen Shi	1
4	Generation of an induced pluripotent stem cell line GWCMCi006-A from a patient with autosomal dominant neurodevelopmental disorder with or without hyperkinetic movements and seizures harboring GRIN1 c.389A > G mutation 2024 ·Stem Cell Research ·Zhen Shi, Huan Liu, (unknown), Zhifang Huang, Wen‐Xiong Chen	2
5	1512MO Perioperative camrelizumab (C) combined with rivoceranib (R) and chemotherapy (chemo) versus chemo for locally advanced resectable gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The first interim analysis of a randomized, phase III trial (DRAGON IV) 2023 ·Annals of Oncology ·Changhui Li, Yingjie Zheng, Zhen Shi, (unknown), Bo Zhang, Zhiqiang Wang, Huijiao Chen, Xiaohua Wang, Peng Zhao, Jiahong Dong, (unknown), Qingjun Zhao, Zheng Zheng, Andrew Zhang, (unknown), (unknown), Fei Yuan, Yuan Tian, Kai Yin, Zheng Zhu	17
6	ATP6V1A variants are associated with childhood epilepsy with favorable outcome 2023 ·Seizure ·Bin Li, (unknown), Xiao‐Rong Liu, Jing-Jing Ji, Yunyan He, Dongming Zhang, Jie Xu, (unknown), Zhen Shi, Jie Wang, (unknown)	5
7	Levetiracetam may be an unsuitable choice for patients with PRRT2-associated self-limited infantile epilepsy 2023 ·BMC Pediatrics ·(unknown), Zhen Shi, Jiahao Cai, (unknown), Xiuying Wang, Haixia Zhu, (unknown), (unknown), Xiaojing Li, (unknown), Wen‐Xiong Chen	0
8	Identification and Verification of Tumor Immune Microenvironment‐Related Prognostic Genes in Kidney Renal Clear Cell Carcinoma 2022 ·BioMed Research International ·(unknown), Yixuan Wang, Yuanjian Huang, Zhen Shi	5
9	Generation of an induced pluripotent stem cell line (GWCMCi005-A) from a patient with Lennox-Gastaut syndrome carrying TANC2 Gln1441Ter mutation 2022 ·Stem Cell Research ·(unknown), Zhen Shi, (unknown), Jiahao Cai, (unknown), Xiaojing Li, Wen‐Xiong Chen	1
10	Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer 2021 ·Clinical Cancer Research ·Zhen Shi, Julia Wulfkuhle, Małgorzata Nowicka, Rosa I. Gallagher, Cristina Saura, Paolo Nucíforo, Isabel Calvo, Jay Andersen, José Luís Passos‐Coelho, Miguel Gil‐Gil, Begoña Bermejo, (unknown), Eva Ciruelos, Patricia Villagrasa, Matthew Wongchenko, Emanuel F. Petricoin, Mafalda Oliveira, Steven J. Isakoff	31
11	Truncating mutation in TANC2 in a Chinese boy associated with Lennox-Gastaut syndrome: a case report 2021 ·BMC Pediatrics ·(unknown), Zhen Shi, (unknown), Wenjuan Li, Xiuying Wang, Haixia Zhu, Xiaojing Li, Wen‐Xiong Chen	5
12	Genetic analysis of 20 patients with hypomyelinating leukodystrophy by trio-based whole-exome sequencing 2021 ·Journal of Human Genetics ·Huifang Yan, (unknown), Thomas L. Kubisiak, Ye Wu, Jiangxi Xiao, (unknown), Yanling Yang, Han Xie, Taoyun Ji, Kai Gao, Dongxiao Li, Hui Xiong, Zhen Shi, Ming Li, Yuehua Zhang, (unknown), Xinhua Bao, Yuwu Jiang, Margit Burmeister, Jingmin Wang	27
13	Abstract 660: Real-world prevalence of metastasis and overall survival (OS) in patients with advanced non-small cell lung cancer (aNSCLC) with KRAS G12C and with or without STK11 or KEAP1 mutations 2021 ·Cancer Research ·Cristina Julián, Navdeep Pal, Anda Gershon, Maria Laura Evangelista, Hans E. Purkey, Peter Lambert, Zhen Shi, Qing Zhang	1
14	Epilepsy in children with leukodystrophies 2020 ·Journal of Neurology ·Jie Zhang, (unknown), (unknown), (unknown), Huifang Yan, Zhen Shi, (unknown), Yuwu Jiang, Jingmin Wang, Ye Wu	8
15	Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib–treated Patients with BRAF V600-mutated Metastatic Melanoma 2019 ·Clinical Cancer Research ·Yibing Yan, Matthew Wongchenko, Caroline Robert, James Larkin, Paolo A. Ascierto, Brigitte Dréno, Michele Maio, Claus Garbe, Paul B. Chapman, Jeffrey A. Sosman, Zhen Shi, Hartmut Koeppen, Jessie J. Hsu, Ilsung Chang, Ivor Caro, Isabelle Rooney, Grant A. McArthur, Antoni Ribas	27
16	FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer 2019 ·Annals of Oncology ·Mafalda Oliveira, Cristina Saura, Paolo Nucíforo, Isabel Calvo, Jens Andersen, José Luís Passos‐Coelho, Miguel Gil Gil, Begoña Bermejo, Debra A. Patt, Eva Ciruelos, Lorena de la Peña, (unknown), Matthew Wongchenko, Zhen Shi, Stina Mui Singel, Steven J. Isakoff	108
17	Targeted next generation sequencing in 112 Chinese patients with intellectual disability/developmental delay: novel mutations and candidate gene 2019 ·BMC Medical Genetics ·Huifang Yan, Zhen Shi, Ye Wu, Jiangxi Xiao, (unknown), Yanling Yang, Ming Li, Kai Gao, Yinyin Chen, Xiaoping Yang, (unknown), (unknown), (unknown), Yuwu Jiang, Jingmin Wang	16
18	A Chinese pedigree with Brown-Vialetto-Van Laere syndrome due to two novel mutations of SLC52A2 gene: clinical course and response to riboflavin 2019 ·BMC Medical Genetics ·(unknown), Zhen Shi, Huifang Yan, Xiaodong Wang, (unknown), Hui Xiong, (unknown), Ye Wu, Yuwu Jiang, Jingmin Wang	11
19	WNK1 Activates Large-Conductance Ca2+-Activated K+ Channels through Modulation of ERK1/2 Signaling 2014 ·Journal of the American Society of Nephrology ·Yingli Liu, Xiang Song, (unknown), Zhen Shi, (unknown), Xiuyan Feng, (unknown), Hui‐Fang Bao, Heping Ma, Douglas C. Eaton, Jieqiu Zhuang, Hui Cai	35
20	Structural and Functional Impact of Cancer-Related Missense Somatic Mutations 2011 ·Journal of Molecular Biology ·Zhen Shi, John Moult	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact